bpc 157 lyme You've probably seen everyone online talking about the new BPC-157 study, and some even claiming it “reduces inflammation by 50%” (study name is Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A BPC-157 Peptide and Lyme Disease:

We welcome your questions about emerging therapies and are here to support your health with proven, safe, and effective treatments

Inflammation and Cytokine Modulation: ERK1/2 pathway activation, reduction of inflammatory cytokines (TNF-, IL-6), AKT phosphorylation enhancement, KRAS expression modulation

This shift definitely improved the rate of primary wound closure rate, in other words, decreased the incidence of wound failure

The physicochemical stability of BPC-157 across various biological environments may contribute to its apparent safety profile, as the peptide appears to be well-tolerated when administered via different routes including oral, subcutaneous, and intramuscular administration